Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.